Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2022-Q1
добавлен 16.12.2023
Sierra Oncology Мультипликаторы 2011-2024 | SRRA
Мультипликаторы по годам Sierra Oncology
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.0 | -2.1 | -18.1 | -70.0 | -177.2 | -34.4 | -89.5 | - | - | - | - |
P/S |
- | 557.9 | - | - | - | - | - | - | - | - | - |
EPS |
-7.1 | -7.7 | -30.3 | -30.2 | -33.7 | -1.6 | -31.5 | -69.1 | -19.2 | - | - |
EV (Enterprise Value) |
197 млн | 72.8 млн | 1.51 млрд | 3.64 млрд | 7.35 млрд | 1.54 млрд | 4.63 млрд | -25.1 млн | -668 тыс. | - | - |
EBITDA per Share |
-7.11 | -6.2 | -23 | -31.3 | -34 | -63.3 | -99.2 | - | - | - | - |
EV/EBITDA |
-2.0 | -0.7 | 1.7 | -67.2 | -151.2 | -32.1 | -129.3 | - | - | - | - |
PEG |
0.11 | -0.03 | 0.4 | -6.68 | -3.31 | -0.36 | 0.04 | - | - | - | - |
P/B |
3.0 | 1.7 | 18.5 | 39.5 | 78.6 | 15.9 | 32.8 | - | - | - | - |
P/CF |
-3.6 | -3.2 | -31.1 | -82.8 | -205.9 | -39.8 | -166.3 | - | - | - | - |
ROE % |
-98.61 | -82.59 | -102.24 | -56.45 | -44.35 | -46.36 | -36.64 | - | - | - | - |
ROA % |
-86.55 | -75.27 | -58.33 | -48.72 | -41.11 | -43.13 | -34.86 | - | - | - | - |
ROCE % |
-98.53 | -66.18 | -77.25 | -55.77 | -44.99 | -46.56 | -24.65 | - | - | - | - |
Current Ratio |
8.2 | 11.3 | 2.3 | 7.3 | 13.7 | 14.3 | 20.5 | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Sierra Oncology
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | -1.33 | - | -2.1 | -1.67 | -1.71 | -1.63 | -1.39 | -1.58 | -3.14 | -7.88 | -6.91 | -7.97 | -7 | -7.68 | -8.38 | -6.44 | -7.72 | -0.2 | -0.19 | -0.2 | -0.26 | -0.3 | -0.5 | -0.43 | -0.35 | -0.38 | -11.03 | -104.1 | -12.83 | -5.85 | -9.37 | -55.04 | -5.77 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | -1.33 | - | -2.09 | -1.66 | -1.69 | - | -1.37 | -1.57 | -1.58 | - | -7 | -8.08 | -7.22 | - | -0.22 | -0.17 | -0.2 | - | -0.19 | -0.2 | -0.26 | - | -0.5 | -0.43 | -0.35 | - | -0.46 | -4.39 | -4.53 | - | -3.41 | -14.7 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-21.35 | -51.49 | -70.95 | -95.43 | -74.23 | -92.63 | -76.26 | -65.89 | -70.92 | -107.49 | -115.65 | -122.65 | -113.60 | -73.75 | -68.30 | -59.84 | -56.45 | -52.52 | -46.60 | -44.84 | -44.35 | -42.12 | -46.30 | -47.86 | -46.36 | -45.29 | -67.19 | -91.36 | -117.79 | -106.55 | -66.24 | -16.78 | 19.85 | 16.50 | 12.82 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-19.95 | -47.43 | -64.94 | -86.80 | -67.36 | -84.12 | -69.47 | -60.69 | -66.00 | -80.60 | -76.30 | -73.05 | -58.33 | -40.02 | -45.71 | -46.81 | -48.72 | -46.05 | -41.60 | -40.79 | -41.11 | -39.07 | -43.00 | -44.49 | -43.13 | -42.30 | -63.46 | -86.72 | -112.09 | -113.52 | -88.42 | -87.63 | -52.77 | -43.84 | -34.08 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-21.32 | -51.41 | -70.84 | -95.25 | -74.02 | -87.73 | -71.35 | -61.03 | -40.27 | -62.81 | -71.64 | -79.12 | -60.27 | -77.26 | -71.71 | -63.85 | -43.15 | -53.90 | -47.66 | -45.00 | -33.59 | -48.39 | -52.44 | -53.92 | -37.62 | -45.21 | -38.00 | -30.01 | -16.77 | -13.54 | -2.73 | 14.35 | 15.76 | 15.76 | 12.53 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | 15.2 | 8.2 | 11.4 | 9.3 | 12.3 | 11.3 | 14.7 | 13.6 | 18.8 | 2.3 | 2.3 | 2.3 | 2.3 | 7.3 | 7.3 | 7.3 | 7.3 | 13.7 | 13.7 | 13.7 | 13.7 | 14.4 | 14.4 | 14.4 | 14.4 | 20.6 | 20.6 | 20.6 | 20.6 | 10.1 | 10.1 | 10.1 | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD